Ipsen Biopharm Ltd in the United Kingdom is seeking an Early Development Asset Lead (EDAL) to drive scientific and program leadership for one or more early-stage assets. You will lead the Early Development Asset Team (EDT) spanning clinical, regulatory, CMC and translational activities, ensuring rigorous strategy and accountable portfolio decisions.
The EDAL will align with Therapeutic Area strategy, championing assigned programs, articulating goals and scientific rationale, and representing the
#J-18808-Ljbffr
Strategic Early Development Asset Lead employer: Biopharma Careers
Boehringer Ingelheim UK is an exceptional employer that fosters a collaborative and innovative work culture, providing employees with the opportunity to grow professionally within the dynamic pharmaceutical industry. With a strong emphasis on employee development and well-being, the company offers comprehensive benefits and a supportive environment that encourages meaningful contributions to healthcare advancements.
